Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.74
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2973
OCGN
Ocugen, Inc. - Common Stock
1.37 USD-2.84%-2.14%+9.60%+31.73%464.58 M USD
2980
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
15.24 USD-5.75%+25.54%+165.04%-10.51%433.17 M USD
3020
AVIR
Atea Pharmaceuticals, Inc. - common stock
5.45 USD-1.09%+1.68%+23.30%+69.78%437.12 M USD
3023
BNTC
Benitec Biopharma Inc. - Common Stock
12.67 USD-1.63%-3.58%+5.50%-23.72%435.27 M USD

Frequently asked questions about Compass Therapeutics, Inc. Common Stock

What is the Compass Therapeutics, Inc. Common Stock stock price today?

The current price of Compass Therapeutics, Inc. Common Stock (CMPX) is 2.50. Over the past 24 hours, the stock has changed by +3.70%. Follow the CMPX chart for real-time price dynamics.

What is the stock ticker of Compass Therapeutics, Inc. Common Stock?

Compass Therapeutics, Inc. Common Stock trades under the ticker CMPX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Compass Therapeutics, Inc. Common Stock stock going up?

CMPX has changed by +3.31% over the last week, +23.15% over the last month, and -28.16% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Compass Therapeutics, Inc. Common Stock?

Compass Therapeutics, Inc. Common Stock currently has a market capitalization of 450.22 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Compass Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Compass Therapeutics, Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Compass Therapeutics, Inc. Common Stock net income for the last quarter?

Compass Therapeutics, Inc. Common Stock reported net income of -25.15 M for the last quarter. The previous quarter showed -18.32 M, which means net income changed by -37.33%.

How many employees does Compass Therapeutics, Inc. Common Stock have?

As of the latest available data, Compass Therapeutics, Inc. Common Stock has 39 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Compass Therapeutics, Inc. Common Stock stock?

You can buy Compass Therapeutics, Inc. Common Stock (CMPX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Compass Therapeutics, Inc. Common Stock stock?

Investing in Compass Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CMPX chart and related analysis on metatrader.com as part of your research.

News